StevenGriffenMD

PubMed

• 13 citations
  Effects of Fructose or Glucose on Circulating ApoCIII and Triglyceride and Cholesterol Content of Lipoprotein Subfractions in Humans.
  Bettina Hieronimus, Steven C. Griffen, Nancy L. Keim, Andrew A. Bremer, Lars Berglund, Katsuyuki Nakajima, Peter J. Havel, Kimber L. Stanhope> ;Journal of Clinical Medicine. 2019 Jun 26
• 127 citations
  Outcome Measures for Artificial Pancreas Clinical Trials: A Consensus Report.
  David M. Maahs, Bruce A. Buckingham, Jessica R. Castle, Ali Cinar, Edward R. Damiano, Eyal Dassau, J. Hans DeVries, Francis J. Doyle, Steven C Griffen, Ahmad Haidar, L...> ;Diabetes Care. 2016 Jul 1
• 160 citations
  Exploring the Potential of the SGLT2 Inhibitor Dapagliflozin in Type 1 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Pilot Study
  Robert R. Henry, Julio Rosenstock, Steven V. Edelman, Sunder Mudaliar, Alexandros-Georgios Chalamandaris, Sreeneeranj Kasichayanula, Allyson Bogle, Nayyar Iqbal, James...> ;Diabetes Care. 2015 Mar 1
• 37 citations
  Use of systems pharmacology modeling to elucidate the operating characteristics of SGLT1 and SGLT2 in renal glucose reabsorption in humans
  Yasong Lu, Steven C. Griffen, David W. Boulton, Tarek A. Leil> ;Frontiers in Pharmacology. 2014 Dec 10
• 154 citations
  Clinical Pharmacokinetics and Pharmacodynamics of Dapagliflozin, a Selective Inhibitor of Sodium-Glucose Co-transporter Type 2
  Sreeneeranj Kasichayanula, Xiaoni Liu, Frank LaCreta, Steven C. Griffen, David W. Boulton> ;Clinical Pharmacokinetics. 2014 Jan 1
• 204 citations
  Characterization of Renal Glucose Reabsorption in Response to Dapagliflozin in Healthy Subjects and Subjects With Type 2 Diabetes
  Ralph A. DeFronzo, Marcus Hompesch, Sreeneeranj Kasichayanula, Xiaoni Liu, Ying Hong, Marc Pfister, Linda Morrow, Bruce R. Leslie, David W. Boulton, Agatha Ching, Fran...> ;Diabetes Care. 2013 Jul 23
• 31 citations
  Effects of sugar‐sweetened beverages on plasma acylation stimulating protein, leptin and adiponectin: Relationships with Metabolic Outcomes
  Reza Rezvani, Katherine Cianflone, John P. McGahan, Lars Berglund, Andrew A. Bremer, Nancy L. Keim, Steven C. Griffen, Peter J. Havel, Kimber L. Stanhope> ;Obesity. 2013 Dec 1
• 41 citations
  Effects of rifampin and mefenamic acid on the pharmacokinetics and pharmacodynamics of dapagliflozin
  Sreeneeranj Kasichayanula, Xiaoni Liu, Steven C. Griffen, Frank LaCreta, David W. Boulton> ;Diabetes, Obesity & Metabolism. 2013 Mar 1
• Loss of coupling between calcium influx, energy consumption and insulin secretion associated with development of hyperglycaemia in the UCD-T2DM rat model of type 2 dia...
  Rountree, A. M.,Reed, B. J.,Cummings, B. P.,Jung, S. R.,Stanhope, K. L.,Graham, J. L.,Griffen, S. C.,Hull, R. L.,Havel, P. J.,Sweet, I. R.> ;Diabetologia. 2013 Apr
• 103 citations
  Consumption of fructose- but not glucose-sweetened beverages for 10 weeks increases circulating concentrations of uric acid, retinol binding protein-4, and gamma-gluta...
  Chad L. Cox, Kimber L. Stanhope, Jean-Marc Schwarz, James L. Graham, Bonnie Hatcher, Steven C. Griffen, Andrew A. Bremer, Lars Berglund, John P. McGahan, Nancy L. Keim...> ;Nutrition & Metabolism. 2012 Jul 24
• 101 citations
  Consumption of fructose-sweetened beverages for 10 weeks reduces net fat oxidation and energy expenditure in overweight/obese men and women
  Chad L. Cox, Kimber L. Stanhope, Jean-Marc Schwarz, James L. Graham, Bonnie Hatcher, Steven C. Griffen, Andrew A. Bremer, Lars Berglund, John P. McGahan, Peter J. Have...> ;European Journal of Clinical Nutrition. 2012 Feb 1
• 45 citations
  Lack of Pharmacokinetic Interactions Between Dapagliflozin and Simvastatin, Valsartan, Warfarin, or Digoxin
  Sreeneeranj Kasichayanula, Ming Chang, Xiaoni Liu, Wen-Chyi Shyu, Steven C. Griffen, Frank P. LaCreta, David W. Boulton> ;Advances in Therapy. 2012 Jan 19
• 52 citations
  Circulating Concentrations of Monocyte Chemoattractant Protein-1, Plasminogen Activator Inhibitor-1, and Soluble Leukocyte Adhesion Molecule-1 in Overweight/Obese Men ...
  Chad L. Cox, Kimber L. Stanhope, Jean-Marc Schwarz, James L. Graham, Bonnie Hatcher, Steven C. Griffen, Andrew A. Bremer, Lars Berglund, John P. McGahan, Nancy L. Keim...> ;The Journal of Clinical Endocrinology and Metabolism. 2011 Sep 28
• 51 citations
  Metabolic responses to prolonged consumption of glucose- and fructose-sweetened beverages are not associated with postprandial or 24-h glucose and insulin excursions
  Kimber L. Stanhope, Steven C. Griffen, Andrew A. Bremer, Roel G Vink, Ernst J. Schaefer, Katsuyuki Nakajima, Jean-Marc Schwarz, Carine Beysen, Lars Berglund, Nancy L. ...> ;The American Journal of Clinical Nutrition. 2011 Jul 1
• 69 citations
  Lack of pharmacokinetic interaction between dapagliflozin, a novel sodium–glucose transporter 2 inhibitor, and metformin, pioglitazone, glimepiride or sitagliptin in h...
  Sreeneeranj Kasichayanula, Xiaoni Liu, W. C. Shyu, W. Zhang, Marc Pfister, Steven C. Griffen, T. Li, Frank LaCreta, David W. Boulton> ;Diabetes, Obesity & Metabolism. 2011 Jan 1
• 7 citations
  Supplementation with EPA or fish oil for 11 months lowers circulating lipids, but does not delay the onset of diabetes in UC Davis-type 2 diabetes mellitus rats.
  Bethany P. Cummings, Kimber L. Stanhope, James L. Graham, Steven C. Griffen, Peter J. Havel> ;The British Journal of Nutrition. 2010 Dec 1
• 57 citations
  Chronic Administration of the Glucagon-Like Peptide-1 Analog, Liraglutide, Delays the Onset of Diabetes and Lowers Triglycerides in UCD-T2DM Rats
  Bethany P. Cummings, Kimber L. Stanhope, James L. Graham, Denis G. Baskin, Steven C. Griffen, Cecilia Nilsson, Anette Sams, Lotte Bjerre Knudsen, Kirsten Raun, Peter J...> ;Diabetes. 2010 Jul 9
• 41 citations
  Dietary fructose accelerates the development of diabetes in UCD-T2DM rats: amelioration by the antioxidant, α-lipoic acid
  Bethany P. Cummings, Kimber L. Stanhope, James L. Graham, Joseph L. Evans, Denis G. Baskin, Steven C. Griffen, Peter J. Havel> ;American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. 2010 May 1
• 1114 citations
  Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans
  Kimber L. Stanhope, Jean-Marc Schwarz, Nancy L. Keim, Steven C. Griffen, Andrew A. Bremer, James L. Graham, Bonnie Hatcher, Chad L. Cox, Artem Dyachenko, Wei Zhang, Jo...> ;The Journal of Clinical Investigation. 2009 May 1
• 81 citations
  Development and characterization of a novel rat model of type 2 diabetes mellitus: the UC Davis type 2 diabetes mellitus UCD-T2DM rat
  Bethany P. Cummings, Erin K. Digitale, Kimber L. Stanhope, James L. Graham, Denis G. Baskin, Benjamin J. Reed, Ian R. Sweet, Steven C. Griffen, Peter J. Havel> ;American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. 2008 Dec 1
• 93 citations
  Consumption of fructose-sweetened beverages for 10 weeks increases postprandial triacylglycerol and apolipoprotein-B concentrations in overweight and obese women
  Michael M. Swarbrick, Kimber L. Stanhope, Sharon S Elliott, James L. Graham, Ronald M. Krauss, Mark P. Christiansen, Steven C. Griffen, Nancy L. Keim, Peter J. Havel> ;The British Journal of Nutrition. 2008 Nov 1
• 156 citations
  Twenty-four Hour Endocrine and Metabolic Profiles Following Consumption of High Fructose Corn Syrup-, Sucrose- Fructose-, and Glucose-Sweetened Beverages with Meals
  Kimber L. Stanhope, Steven C. Griffen, Brandi R Bair, Michael M. Swarbrick, Nancy L. Keim, Peter J. Havel> ;The American Journal of Clinical Nutrition. 2008 May 1
• 270 citations
  Increased Toll-Like Receptor (TLR) 2 and TLR4 Expression in Monocytes from Patients with Type 1 Diabetes: Further Evidence of a Proinflammatory State
  Sridevi Devaraj, Mohan R. Dasu, Jason Rockwood, William E. Winter, Steven C. Griffen, Ishwarlal Jialal> ;The Journal of Clinical Endocrinology and Metabolism. 2008 Feb 1
• 137 citations
  Evidence of Increased Inflammation and Microcirculatory Abnormalities in Patients with Type 1 Diabetes and Their Role in Microvascular Complications
  Sridevi Devaraj, Anthony T.W. Cheung, Ishwarlal Jialal, Steven C. Griffen, Danh V. Nguyen, Nicole Glaser, Thomas T. Aoki> ;Diabetes. 2007 Aug 8
• 34 citations
  Concomitant reduction of low-density lipoprotein-cholesterol and biomarkers of inflammation with low-dose simvastatin therapy in patients with type 1 diabetes.
  Ishwarlal Jialal, Eric Miguelino, Steven C. Griffen, Sridevi Devaraj> ;The Journal of Clinical Endocrinology and Metabolism. 2007 Aug 1
• Join now to see all